Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cellular Oncology

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13402-017-0358-0PMID 29134466PMCID PMC12995217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer

  2016cited by this paper
• Next Generation

  2016cited by this paper
• Moonlighting proteins in cancer.

  2016cited by this paper
• Implications of Differential Expression of β-Catenin in Oral Carcinoma.

  2016cited by this paper
• The role of lymphangiogenesis and angiogenesis in tumor metastasis

  2016cited by this paper
• Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study

  2016cited by this paper
• The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma.

  2015cited by this paper
• Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.

  2015influential reference
• Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression

  2015influential reference
• Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling.

  2015cited by this paper
• Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer

  2015cited by this paper
• Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells

  2015cited by this paper
• BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer

  2015cited by this paper
• Mechanisms of Invasion in Head and Neck Cancer.

  2015cited by this paper
• A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity

  2014cited by this paper
• 4. TRIALS AND TRIBULATIONS OF CLIO

  2014cited by this paper
• 516: Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells

  2014cited by this paper
• Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells

  2014cited by this paper
• MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway

  2014cited by this paper
• Fluctuating Roles of Matrix Metalloproteinase-9 in Oral Squamous Cell Carcinoma

  2013cited by this paper
• The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment.

  2013cited by this paper
• Interactions between Twist and other core epithelial–mesenchymal transition factors are controlled by GSK3-mediated phosphorylation

  2013cited by this paper
• Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors

  2013cited by this paper
• Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies

  2012cited by this paper
• Metastasis from oral cancer: an overview.

  2012cited by this paper
• Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer.

  2012cited by this paper
• Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma

  2012cited by this paper
• Suppression of nasopharyngeal carcinoma cell by targeting β-catenin signaling pathway.

  2012cited by this paper
• Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The molecular biology of head and neck cancer

  2011cited by this paper
• Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.

  2011cited by this paper
• Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.

  2010cited by this paper
• Reviewsynthase kinase 3 beta: can it be a target for oral cancer

  2010cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010influential reference
• Glycogen synthase kinase 3 beta: can it be a target for oral cancer

  2010cited by this paper
• MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.

  2009cited by this paper
• Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.

  2008cited by this paper
• Transforming Growth Factor-β1 Promotes Matrix Metalloproteinase-9–Mediated Oral Cancer Invasion through Snail Expression

  2008cited by this paper
• Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancer

  2007cited by this paper
• Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.

  2005cited by this paper
• Matrix metalloproteinase‐2 (MMP‐2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP‐ribose) polymerase (PARP) in vitro

  2004cited by this paper
• Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.

  2004cited by this paper
• Inhibition of lymphangiogenesis‐related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270

  2004cited by this paper
• Calcium-induced Matrix Metalloproteinase 9 Gene Expression Is Differentially Regulated by ERK1/2 and p38 MAPK in Oral Keratinocytes and Oral Squamous Cell Carcinoma*

  2004cited by this paper
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004cited by this paper
• Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development

  2003cited by this paper
• Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.

  2003cited by this paper
• Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.

  2002cited by this paper
• Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix.

  2002cited by this paper
• Grammar Engineering for CCG using Ant and XSLT ∗

  2001cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001influential reference
• Expression of tissue inhibitor of matrix metalloproteinase‐2 correlates with activation of matrix metalloproteinase‐2 and predicts poor prognosis in tongue squamous cell carcinoma

  2001cited by this paper
• The pilot study.

  2000cited by this paper
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000influential reference
• Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

  1998influential reference
• Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).

  1995cited by this paper
• Molecular biology of head and neck cancer.

  1994cited by this paper
• Production of both 92- and 72-kDa gelatinases by bone cells.

  1992cited by this paper
• Tumorigenesis and Neoplastic Progression Matrix Metalloproteinase 3 Is Present in the Cell Nucleus and Is Involved in Apoptosis

  year unknowncited by this paper

• Knockdown of HOXD13 in Oral Squamous Cell Carcinoma Inhibited its Proliferation, Migration, and Influenced Fatty Acid Metabolism

  2025cites this paper
• Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies

  2024cites this paper
• MARK4在甲基苯丙胺诱导急性肾损伤中的作用

  2024cites this paper
• Unveiling the dual anti-viral and anti-bacterial potential of Tridax procumbens: integrating system biology and molecular modeling for therapeutic insights

  2024cites this paper
• Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits.

  2023cites this paper
• Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer

  2023cites this paper
• Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance.

  2023cites this paper
• Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance.

  2023cites this paper
• Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases

  2023cites this paper
• Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma

  2023cites this paper
• Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma.

  2023cites this paper
• Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro

  2023influential citation
• Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

  2022cites this paper
• Polymorphisms and haplotypes of TLR-4/9 associated with bacterial infection, gingival inflammation/recession and oral cancer.

  2022cites this paper
• Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications.

  2022cites this paper
• Therapeutic implications and clinical manifestations of thymoquinone.

  2022cites this paper
• Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases

  2022cites this paper
• Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future

  2022cites this paper
• Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities.

  2022cites this paper
• Epigallocatechin 3-gallate: From green tea to cancer therapeutics.

  2022cites this paper
• ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).

  2021cites this paper
• Proteolytic Processing of CD44 and Its Implications in Cancer

  2021cites this paper
• Immunohistochemical Expression of MMP-9, TIMP-1, and Vimentin and its Correlation With Inflammatory Reaction and Clinical Parameters in Oral Epithelial Dysplasia

  2021cites this paper
• Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.

  2021cites this paper
• GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis

  2021cites this paper
• Glycogen synthase kinase‐3β inactivation promotes cervical cancer progression, invasion, and drug resistance

  2021cites this paper
• Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

  2021cites this paper
• The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer

  2020cites this paper
• Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma

  2020cites this paper
• Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin‐resistance, invasion and stemness acquisition

  2020influential citation
• Hypothesis validation of rosiglitazone a potential inhibitor against glycogen synthase kinase-3β, for the management of multifaceted pathophysiology of the diabetic wound: An insilico study.

  2020cites this paper
• Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion

  2020cites this paper
• Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer.

  2020cites this paper
• Bio-genesis and deregulation of circular ribonucleic acid and their role in human cancer

  2020cites this paper
• Genetics and Molecular Mechanisms in Oral Cancer Progression

  2019cites this paper
• ZO-2 Suppresses Cell Migration Mediated by a Reduction in Matrix Metalloproteinase 2 in Claudin-18-Expressing Lung Adenocarcinoma A549 Cells.

  2019cites this paper
• Oral Cancer Detection

  2019cites this paper
• Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta‐analysis

  2019cites this paper
• Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma

  2019cites this paper
• Secreted amphiregulin promotes vincristine resistance in oral squamous cell carcinoma.

  2019cites this paper
• c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity.

  2019cites this paper
• HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma

  2019cites this paper
• Comparison of Matrix Metalloproteinases 2 and 9 Levels in Saliva and Serum of Patients with Head and Neck Squamous Cell Carcinoma and Healthy Subjects

  2019cites this paper
• Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.

  2018cites this paper